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Abstract
Background: National or regional population-based HIV prevalence surveys have small sample sizes at district or
sub-district levels; this leads to wide confidence intervals when estimating HIV prevalence at district level for
programme monitoring and decision making. Health facility programme data, collected during service delivery is
widely available, but since people self-select for HIV testing, HIV prevalence estimates based on it, is subject to
selection bias. We present a statistical annealing technique, Hybrid Prevalence Estimation (HPE), that combines a
small population-based survey sample with a facility-based sample to generate district level HIV prevalence
estimates with associated confidence intervals.
Methods: We apply the HPE methodology to combine the 2011 Uganda AIDS indicator survey with the 2011
health facility HIV testing data to obtain HIV prevalence estimates for districts in Uganda. Multilevel logistic
regression was used to obtain the propensity of testing for HIV in a health facility, and the propensity to test was
used to combine the population survey and health facility HIV testing data to obtain the HPEs. We assessed
comparability of the HPEs and survey-based estimates using Bland Altman analysis.
Results: The estimates ranged from 0.012 to 0.178 and had narrower confidence intervals compared to survey-
based estimates. The average difference between HPEs and population survey estimates was 0.00 (95% CI: − 0.04,
0.04). The HPE standard errors were 28.9% (95% CI: 23.4–34.4) reduced, compared to survey-based standard errors.
Overall reduction in HPE standard errors compared survey-based standard errors ranged from 5.4 to 95%.
Conclusions: Facility data can be combined with population survey data to obtain more accurate HIV prevalence
estimates for geographical areas with small population survey sample sizes. We recommend use of the
methodology by district level managers to obtain more accurate HIV prevalence estimates to guide decision
making without incurring additional data collection costs.
Keywords: Combining, Bias, Population survey, Health Information System, Hybrid Prevalence Estimate,
District Health Information System
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Background
Accurate data are needed for monitoring health pro-
grammes and interventions and for appropriate allocation
of resources. In most of sub-Saharan Africa (SSA), where
the HIV/AIDS epidemic is generalized, national popula-
tion surveys, such as AIDS Indicator Surveys (AIS), are
preferred to provide reliable health indicator estimates for
programme monitoring [1]. The surveys are however de-
signed to provide estimates at national and regional levels,
but small sample sizes at district or sub-district levels lead
to less reliable indicator estimates, that have wider confi-
dence intervals [1–4].
Health Information Systems such as the District Health
Information System (DHIS2) provide another source of
information that can be used for monitoring the HIV/
AIDS epidemic. This data is collected more regularly,
available at more decentralized levels, e.g. districts and
costs less to collect. WHO, UNAIDS and other develop-
ment partners recommend use of routine facility data in
addition to other data sources to monitor programme per-
formance, assess intervention coverage and measure levels
of disease in a population [5]. Use of routine health facility
data informed the adjustments in HIV prevalence esti-
mates in many countries in Eastern and Southern Africa
[6]. Several other studies highlight the utility of data from
routine service delivery in informing service delivery deci-
sions [7, 8]. Routine service delivery data, however, are
collected only on individuals who attend/access health fa-
cilities and thus provide potentially biased estimates of
population indicators.
In addition, development partners and ministries of
health in middle and low-income countries have invested
in electronic health information systems including the
DHIS2, to improve the quality and timeliness of data from
the systems. In Uganda, Ministry of Health (MoH) with
support from development partners conduct quarterly re-
views to validate data reported into DHIS2 [9]. With this
investment, there is a need to find ways to utilize this
source of information to inform service delivery decisions.
Combining routine data with a relatively small sample of
respondents from population survey data has been found
to produce more accurate indicator estimates [10, 11].
Statistical models in packages such as SPECTRUM or
THEMBISA attempt to use both routine and population
survey data to calculate HIV/AIDS indicators. Model in-
puts such as ANC prevalence, mortality, number of indi-
viduals on ART and recent HIV prevalence when not
available, complicate their use [12]. A simpler and more
robust method may be easier to use and give good results.
Larmarange and Bendaud obtained district level estimates
from population survey data from 17 countries using a ker-
nel density approach implemented in PrevR [13]. In dis-
tricts with inadequate number of observations in the survey
sample, estimates were obtained based on observations
from neighboring districts or administrative units and were
categorized as “uncertain” estimates [13]. Using a similar
approached, PrevR, UNAIDS found “uncertain” estimates
in up to 86% of the districts in Mozambique and in 79% of
the districts in Uganda [13, 14].
In this study, we explore use of the readily available
health facility service delivery data in combination with
population survey data to obtain more accurate HIV
prevalence estimates at district level for monitoring in-
terventions and disease impact in the general population.
We implement the Hybrid Prevalence Estimation (HPE)
methodology to obtain HIV prevalence estimate and
95% confidence interval for districts in Uganda. The esti-
mation process accounts for sample size limitations as-
sociated with population survey data at district level and
self-selection bias associated with health facility testers, a
limitation that many researchers have not been able to
address adequately [2–4, 15–18].
Methods
Data sources
We analyzed data from the 2011 Uganda AIDS Indi-
cator Survey (UAIS) and health facility HIV testing
data from the national DHIS2 collected during 2011.
UAIS data was downloaded from the Measure DHS
website www.measuredhs.com after obtaining consent
from ICF/Macro international, while health facility
testing data was extracted from the DHIS2 hosted at
MoH after obtaining written permission from MoH.
Ethical clearance to conduct this study was obtained
from the University of Witwatersrand Human Re-
search Ethics Committee (HREC) and Uganda Na-
tional Council for Science and Technology (UNCST).
Uganda AIDS Indicator survey
The UAIS is a nationally representative, population-based,
HIV serological survey, designed to provide HIV prevalence
estimates at national and regional levels [19]. The survey
used a two-stage cluster sampling design. For the 2011 sur-
vey, Uganda was divided into 10 geographical regions each
consisting of 8–15 neighboring districts. Clusters were ran-
domly selected from each region with probability propor-
tional to number of households in the cluster. The
estimated number of households per cluster were projec-
tions from the 2002 National Population and Housing Cen-
sus (NPHC) [20]. Clusters were enumeration areas from
the 2002 NPHC. Sample sizes were allocated equally across
the 10 geographical regions. A systematic sample of 25
households were then selected from each cluster using the
2002 NPHC sampling frame. All adults present in the se-
lected household and who consented to participate in the
survey were interviewed [19]. More details about the survey
are available from www.measuredhs.com.
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For this study, a total of 19,475 individuals (8532 men
and 10,943 women) aged 15–49 years and tested for HIV
during the survey were considered. Variables included in
the analysis were (i) at cluster level: area of residence
(urban/rural) and region of the country and at (ii) individ-
ual level: respondents’ gender, marital status, education
level attained, number of sexual partners including hus-
band/wife in the 12months preceding the survey, employ-
ment status and distance to nearest health facility.
A multilevel logistic regression model was fitted to the
UAIS data to obtain the respondents’ probability of testing
for HIV in a health facility. The model was fitted using a
total of 470 clusters. The average number of observations
per cluster were 45(min = 11 and max = 64). Unequal sam-
ple selection probabilities were accounted for by incorpor-
ating scaled sampling weights. Carle’s methodology was
applied to adjust/scale the sampling weights [21]. The
models were fitted using maximum likelihood method in
Stata statistical software, release 15 [22].
Survey respondents were considered to have tested for
HIV at a health facility if they reported that they tested for
HIV in health facility and received their test results in the
12months preceding the survey. Pregnant or breastfeeding
women who tested for HIV during antenatal care attend-
ance and individuals who tested at an HIV care centre
such as The AIDS Support Organization (TASO) and
AIDS Information Centre (AIC) were included in the ana-
lysis. Health facilities included facilities owned and man-
aged by government (public) and private organizations
that reported HIV testing data to the national DHIS2.
Health facility data
Health facility HIV testing data comprised of data re-
ported to the national DHIS2. The system was developed
to provide accurate, timely and quality routine data for
monitoring and planning for the health sector in Uganda
[9, 23]. Training and technical support from development
partners and MoH has led to improvement in the quality
and reliability of data in the system [9]. Aggregated HIV
testing data is reported by health facilities to the DHIS2
on a monthly basis. The data includes HIV testing at all
inpatient and outpatient departments in health facilities.
For 2011 reporting period, data was disaggregated by age
(i.e. 0–14, 15–49 and 50+ years) and gender (male and fe-
male). For this study, we considered males and females
aged 15–49 years.
Indicators considered for this analysis were: number of
individuals who were tested and received their HIV test
results (A) and number of individuals who tested HIV
positive (B). For ANC data, we considered number of
pregnant women counseled, tested and received their HIV
test results (C) at first antenatal visit and the number who
tested HIV positive (D). HIV counseling and testing algo-
rithm in Uganda recommends HIV testing for any
individual whose most recent negative HIV test result was
conducted more than 3 months prior to the current visit
to the health facility [24]. Some individuals may test mul-
tiple times within a year but may not disclose to health
workers resulting in double counting, a key limitation for
this study. Furthermore, some pregnant women may test
for HIV before seeking antenatal care and test again dur-
ing antenatal attendance leading to double counting in the
data reported to the national DHIS2.
Variables based on DHIS2 data were defined as
follows;
– Total number of individuals tested for HIV = (A +C)
– Number HIV positive = (B +D)
– Total number of males tested for HIV = males in A
– Number of males tested HIV positive = males in B
– Total number of females tested for HIV = (females
in A) + C
– Number of female tested HIV positive = (females
in B) +D
Addressing possible bias in health facility data
Routine facility data collected as part of service delivery
consists of individuals who self-select, limiting its’ use for
general population health indicator monitoring. To obtain
general population indicator estimates, some researchers
have used census projections as denominators, however
this approach often results in coverage estimates that are
greater than 100% [25]. Population surveys are preferred
to obtain health indicator denominators since their design
takes into account population distribution in the country
[25–28]. The UAIS comprise two subpopulations, namely
individuals who tested for HIV in a health facility in the
12months preceding the survey (the facility testers) and
those who did not test for HIV in a health facility (the
non-facility testers) for the same period. We assume that
the UAIS estimates of HIV prevalence for those who
tested for HIV in a health facility and for those who did
not test for HIV in a health facility are accurate at regional
levels, since estimates of domain proportions from a
multistage survey are unbiased. We apply this assumption
to adjust the denominators of the DHIS2 data so that at
the regional level, DHIS2 HIV prevalence estimates are
similar to UAIS prevalence estimates. The adjustment
process was carried out as follows:
1. We obtained the HIVs prevalence k^ f among health
facility testers in each region in the UAIS data.
2. We adjusted denominators in the DHIS2 data for
each region using nrajdusted ¼ nposk^ f
, where npos is the
observed number of individuals who tested HIV
positive in each region in the DHIS2 data.
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3. Calculated an adjustment factor (δf) for each region,
using δ f ¼ n
r
ajdusted
nr
, where nr is the observed number
of individuals who tested for HIV in each region
from the DHIS2 data.
4. We applied the adjustment factor (δf), to obtain
ndajdusted, the adjusted number of individuals who
tested for HIV in a health facility at district level
using, ndajdusted ¼ δ f nd, where nd is the observed
number of individuals tested for HIV at district level.
5. HIV prevalence (Pf) based on DHIS2 adjusted data
in the district was then obtained as a ratio of npos,
the total observed positives and nadjusted the
adjusted number of individuals who tested for HIV
in the district, i.e. P f ¼ nposndajdusted
Hybrid prevalence estimation methodology
We consider n individuals in the UAIS to include nc indi-
viduals who tested for HIV at a health facility during the
12months preceding the survey and know their test result
and nc individuals who did not test for HIV at a health
facility and therefore do not know their HIV status. i.e.
n ¼ nc þ nc . Using health facility prevalence computed in
step 5 above, we computed district HIV prevalence as a
weighted average of prevalence from DHIS2 data, Pf and
prevalence among individuals who did not test for HIV in
a health facility, P^s estimated from the UAIS data.
P^ ¼ π^cP f þ 1−π^cð ÞP^s ð1Þ
where;
P^ – HPE/combined estimate, π^c – the estimated prob-
ability of testing for HIV in a health facility, Pf− Adjusted
HIV prevalence for individuals tested at a health facility
and P^s – HIV prevalence for individuals tested during
the survey and had not tested for HIV in a health facility
in the 12 months preceding the survey. We estimated π^c
from UAIS data using multilevel logistic regression
adjusting for both individual and cluster level factors.
Applying this model, we account for clustering at cluster
level [25]. Although the probability of testing for HIV in
a health facility was obtained at individual level, we used
average district level probability of testing to combine
the estimates. Since average probability of HIV testing is
obtained from a survey sample containing both facility
and non-facility testers, we estimate the variance and
standard errors (SE) for the HPE respectively as follows;
Var P^
  ¼ 1
n
P^s 1−P^s
 
1−π^cð Þ þ 1−π^cð Þ P f −P^s
 2n o
and SE ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
var P^
 q
ð2Þ
We assess accuracy of the HPEs compared to survey-
based prevalence estimates by computing the percentage
change in standard errors. We further assessed agree-
ment of the estimates obtained using the HPE method-
ology with those from population survey method (Direct
population survey estimate) using a Bland Altman ana-
lysis [26, 27].
All analysis was carried out in Stata statistical analysis
software, Release 15 [22] and R version 3.5.0 [28].
Results
Of the 19,475 individuals, 6729 (34.6%) tested for HIV in
a health facility in the 12 months preceding the survey.
HIV prevalence among those who tested in a health fa-
cility was 0.084 compared to 0.068 among those who did
not test in a health facility (Table 1).
From health facility data, national (unadjusted) HIV
prevalence was 0.058 (Male: 0.057 Female: 0.059). A total
of 4,758,991 (female: 73.7%) individuals were tested for
HIV in a health facility. (Table 1). DHIS2 HIV positivity
by gender is presented Additional file 1: Appendix 1.
Weighting/annealing factor
Overall (national) average propensity to test in a health fa-
cility was 0.35 (male: 0.27, female:0.41). It ranged from
0.001 to 0.95 (Fig. 1). Mid Northern region had the high-
est average propensity to test for HIV in health facility,
0.44 (male: 0.40 and female: 0.49) while Mid-Eastern re-
gion had the lowest, 0.25 (male: 0.16, female: 0.32) (Fig. 1).
Hybrid prevalence estimates
HIV prevalence was highest in Central 1 region (0.11) and
lowest in Mid-Western and Mid-Eastern regions (0.04 in
each region). District level HPEs ranged from 0.01 to 0.18.
Average HIV prevalence by region were; Central 1: 0.11
(min; 0.06, max; 0.18), Central 2: 0.10 (0.08, 0.17), East
Central: 0.05 (0.02, 0.09), Mid-Eastern: 0.04 (0.01, 0.09),
Mid Northern: 0.09 (0.05, 0.14), Mid-Western: 0.08 (0.03,
0.16), North East:0.04 (0.04, 0.10), South West: 0.08 (0.04,
0.13) and West Nile: 0.04 (0.03, 0.07) (Table 2). Table 2
also presents HPE, survey and DHIS2 based district HIV
prevalence estimates by district.
Figure 2 presents HIV prevalence maps in; both sexes
(map a); in males (map b); and in females (map c). HPEs
had similar patterns for both sexes, males and females
consistent with the regional level prevalence estimates
from population survey in Table 1. Districts in Central 1
region, Mid northern region, Island, and those along
lake shores had higher overall, male and female HIV
prevalence estimates (Fig. 2, and Additional file 1: Ap-
pendix 2) while districts in mid-eastern and West Nile
region had lower HIV prevalence estimates. HPEs were
not calculated for two districts (Bukwo in mid-eastern
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region and Ntoroko in mid-western region) because
UAIS data points was not available for those districts.
Figure 3 compares district HIV prevalence estimates
from population survey and HPE while in Fig. 4, we
compare HPE and the adjusted DHIS2 data for se-
lected districts. Prevalence comparison between HPE
and survey for all districts is presented in Additional
file 1: Appendix 3. The figures show that HPEs had
narrower confidence intervals compared to direct sur-
vey estimates indicating an improvement in the preci-
sion of the estimates.
Of the 110 districts, 51 (46.4%) had lower HPEs (point
estimates) and 59 (53.6%) had higher HPE compared to
the survey-based district prevalence estimates (Fig. 3,
Additional file 1: Appendix 3).
HPEs were however lower than the DHIS2 prevalence
estimates in 74 (67.3%) and higher in 36 (32.7%) of the
districts in Uganda (Fig. 4, Additional file 1: Appendix 4).
A joint comparison of the HP estimates with both
survey-based and health facility-based prevalence esti-
mates show that 33 (30.0%) of the districts had lower
HPEs while 18 (16.4%) had higher estimates compared
Table 1 Regional level HIV prevalence estimates
Region Population Survey prevalence (in proportion) (Number HIV+) Health Facility
Prevalence
(Number
HIV+)a
Overall Tested in Health Facility Not tested in health-Facility
Central 1 0.106 (185) 0.123 (74) 0.096 (111) 0.094 (40,880)
Central 2 0.090 (166) 0.079 (57) 0.096 (109) 0.070 (36,125)
East Central 0.057 (108) 0.081 (39) 0.048 (69) 0.037 (17,207)
Kampala 0.071 (156) 0.080 (62) 0.066 (94) 0.098 (25,447)
Mid-Eastern 0.041 (88) 0.042 (24) 0.041 (64) 0.040 (13,926)
North East 0.053 (98) 0.053 (45) 0.052 (53) 0.026 (15,106)
Mid Northern 0.083 (159) 0.099 (81) 0.071 (78) 0.076 (39,559)
Mid-Western 0.083 (170) 0.089 (63) 0.080 (107) 0.062 (52,102)
West Nile 0.048 (88) 0.055 (33) 0.045 (55) 0.031 (7758)
South Western 0.080 (149) 0.103 (64) 0.069 (85) 0.053 (29,338)
National 0.073 (1367) 0.084 (542) 0.068 (825) 0.058 (277,448)
NOTE: Regional HIV Prevalence from population survey and health facility testing data
aHIV prevalence from the unadjusted health facility data
Fig. 1 Propensity to test for HIV in a health facility
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Table 2 HPE HIV prevalence estimates, (HPE, Survey and unadjusted DHIS2)
Region and
District
HPE Population Survey Facility Data
(unadjusted)Estimate (95% CI) Estimate (95% CI)
Central 1
Bukomansimbi 0.064 (0.027, 0.101) 0.074 (0.021, 0.127) 0.083
Butambala 0.103 (0.017, 0.190) 0.124 (0.000, 1.000) 0.063
Gomba 0.090 (0.036, 0.144) 0.158 (0.060, 0.257) 0.063
Kalangala 0.138 (0.064, 0.212) 0.195 (0.000, 1.000) 0.135
Kalungu 0.142 (0.065, 0.219) 0.102 (0.025, 0.179) 0.086
Lwengo 0.143 (0.090, 0.195) 0.157 (0.090, 0.223) 0.105
Lyantonde 0.121 (0.012, 0.229) 0.109 (0.000, 1.000) 0.085
Masaka 0.178 (0.129, 0.227) 0.156 (0.096, 0.216) 0.131
Mpigi 0.097 (0.065, 0.129) 0.108 (0.059, 0.158) 0.101
Rakai 0.081 (0.053, 0.109) 0.076 (0.042, 0.109) 0.067
Sembabule 0.072 (0.037, 0.106) 0.067 (0.015, 0.118) 0.078
Wakiso 0.107 (0.090, 0.124) 0.096 (0.070, 0.123) 0.094
Central 2
Buikwe 0.083 (0.060, 0.106) 0.079 (0.042, 0.116) 0.086
Buvuma 0.170 (0.102, 0.238) 0.185 (0.096, 0.273) 0.085
Kayunga 0.069 (0.041, 0.096) 0.065 (0.030, 0.100) 0.049
Kiboga 0.090 (0.035, 0.145) 0.063 (0.008, 0.117) 0.069
Kyankwanzi 0.111 (0.049, 0.173) 0.128 (0.054, 0.203) 0.045
Luwero 0.094 (0.066, 0.123) 0.080 (0.044, 0.117) 0.075
Mityana 0.136 (0.097, 0.175) 0.104 (0.058, 0.151) 0.125
Mubende 0.077 (0.053, 0.101) 0.094 (0.056, 0.132) 0.057
Mukono 0.090 (0.063, 0.116) 0.092 (0.054, 0.129) 0.069
Nakaseke 0.073 (0.038, 0.109) 0.083 (0.025, 0.141) 0.083
Nakasongola 0.083 (0.041, 0.125) 0.076 (0.018, 0.134) 0.088
East Central
Bugiri 0.037 (0.019, 0.055) 0.027 (0.008, 0.045) 0.029
Buyende 0.055 (0.020, 0.091) 0.044 (0.006, 0.081) 0.033
Iganga 0.062 (0.037, 0.087) 0.054 (0.025, 0.082) 0.035
Jinja 0.088 (0.064, 0.112) 0.090 (0.056, 0.124) 0.057
Kaliro 0.036 (0.001, 0.071) 0.046 (0.000, 0.098) 0.023
Kamuli 0.051 (0.034, 0.068) 0.058 (0.033, 0.082) 0.036
Luuka 0.023 (0.005, 0.042) 0.018 (0.000, 0.037) 0.018
Mayuge 0.042 (0.023, 0.062) 0.092 (0.043, 0.140) 0.036
Namayingo 0.089 (0.043, 0.135) 0.093 (0.035, 0.151) 0.079
Namutumba 0.037 (0.011, 0.062) 0.038 (0.000, 0.076) 0.030
Kampala 0.076 (0.067, 0.085) 0.071 (0.058, 0.084) 0.098
Mid Eastern
Budaka 0.065 (0.018, 0.111) 0.050 (0.007, 0.093) 0.029
Bududa 0.025 (0.000, 0.055) 0.046 (0.006, 0.087) 0.014
Bulambuli 0.026 (0.000, 0.055) 0.023 (0.000, 0.053) 0.040
Busia 0.068 (0.038, 0.097) 0.074 (0.037, 0.112) 0.063
Butaleja 0.026 (0.003, 0.049) 0.026 (0.001, 0.052) 0.018
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Table 2 HPE HIV prevalence estimates, (HPE, Survey and unadjusted DHIS2) (Continued)
Region and
District
HPE Population Survey Facility Data
(unadjusted)Estimate (95% CI) Estimate (95% CI)
Kapchorwa 0.092 (0.000, 0.186) 0.097 (0.000, 1.000) 0.021
Kibuku 0.036 (0.000, 0.074) 0.014 (0.000, 0.040) 0.027
Kween 0.013 (0.000, 0.032) 0.007 (0.000, 0.022) 0.022
Manafwa 0.034 (0.014, 0.055) 0.034 (0.006, 0.062) 0.035
Mbale 0.037 (0.022, 0.052) 0.035 (0.015, 0.055) 0.070
Pallisa 0.012 (0.002, 0.022) 0.007 (0.000, 0.019) 0.021
Sironko 0.051 (0.022, 0.079) 0.050 (0.020, 0.080) 0.030
Tororo 0.071 (0.044, 0.097) 0.069 (0.041, 0.098) 0.044
Mid Northern
Agago 0.080 (0.047, 0.113) 0.046 (0.011, 0.081) 0.071
Alebtong 0.066 (0.035, 0.097) 0.058 (0.016, 0.100) 0.068
Amolatar 0.108 (0.058, 0.159) 0.158 (0.079, 0.237) 0.078
Amuru 0.059 (0.027, 0.091) 0.028 (0.000, 0.061) 0.043
Apac 0.062 (0.043, 0.080) 0.052 (0.022, 0.082) 0.081
Dokolo 0.070 (0.041, 0.099) 0.055 (0.015, 0.094) 0.061
Gulu 0.090 (0.066, 0.113) 0.100 (0.049, 0.151) 0.086
Kitgum 0.081 (0.042, 0.121) 0.083 (0.024, 0.141) 0.072
Kole 0.047 (0.023, 0.070) 0.029 (0.001, 0.057) 0.051
Lamwo 0.088 (0.041, 0.134) 0.121 (0.043, 0.198) 0.071
Lira 0.108 (0.079, 0.138) 0.111 (0.066, 0.157) 0.098
Nwoya 0.123 (0.033, 0.212) 0.163 (0.000, 1.000) 0.052
Otuke 0.136 (0.048, 0.224) 0.128 (0.000, 1.000) 0.075
Oyam 0.066 (0.043, 0.089) 0.068 (0.035, 0.100) 0.058
Pader 0.140 (0.088, 0.192) 0.165 (0.090, 0.239) 0.087
Mid Western
Buliisa 0.065 (0.013, 0.117) 0.038 (0.000, 0.785) 0.065
Bundibugyo 0.032 (0.010, 0.054) 0.032 (0.000, 0.071) 0.028
Hoima 0.075 (0.050, 0.100) 0.086 (0.051, 0.121) 0.053
Kabarole 0.159 (0.124, 0.194) 0.137 (0.094, 0.180) 0.099
Kamwenge 0.065 (0.037, 0.093) 0.054 (0.023, 0.086) 0.050
Kasese 0.066 (0.046, 0.085) 0.050 (0.027, 0.073) 0.050
Kibaale 0.068 (0.045, 0.091) 0.079 (0.046, 0.113) 0.049
Kiryandongo 0.059 (0.019, 0.098) 0.071 (0.016, 0.126) 0.048
Kyegegwa 0.118 (0.058, 0.177) 0.127 (0.056, 0.198) 0.046
Kyenjojo 0.077 (0.047, 0.106) 0.121 (0.071, 0.172) 0.070
Masindi 0.063 (0.035, 0.091) 0.060 (0.023, 0.097) 0.062
North East
Abim 0.066 (0.004, 0.128) 0.098 (0.000, 1.000) 0.031
Amudat 0.090 (0.000, 0.204) 0.049 (0.000, 0.899) 0.022
Amuria 0.102 (0.067, 0.138) 0.102 (0.056, 0.148) 0.039
Bukedea 0.044 (0.014, 0.074) 0.045 (0.002, 0.088) 0.022
Kaabong 0.037 (0.016, 0.057) 0.021 (0.000, 0.044) 0.022
Kaberamaido 0.081 (0.045, 0.117) 0.061 (0.020, 0.102) 0.034
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to both the survey and health facility-based prevalence
estimates.
Precision of HPE and population survey estimates
Standard errors of the HPEs were generally lower com-
pared to SEs from survey-based estimates (Fig. 5). Of the
districts, 105 (95.5%) had lower HPE SEs compared to
SEs from survey-based estimates. Overall, the HPE
standard errors were decreased by 28.9% (95% CI: 23.4–
34.4) compared to survey-based standard errors.
Similarity of HPE and survey-based estimates
On average, there is no difference between survey and
HPE estimates, 0.0 (95% CI: − 0.04,0.04) (Fig. 6a). Aver-
age difference for males was − 0.01 (95% CI: − 0.05,0.03)
while for females was 0.00 (95% CI: − 0.06,0.06). Al-
though there seems to be a bias (0.01) when assessing
the agreement between HP and survey-based estimates
for males (Fig. 6b), the 95% confidence interval of the
difference between the estimates are narrow. Addition-
ally, there was no systematic pattern of the points as the
average of the estimates increases.
Table 2 HPE HIV prevalence estimates, (HPE, Survey and unadjusted DHIS2) (Continued)
Region and
District
HPE Population Survey Facility Data
(unadjusted)Estimate (95% CI) Estimate (95% CI)
Katakwi 0.074 (0.041, 0.107) 0.080 (0.034, 0.126) 0.035
Kotido 0.052 (0.009, 0.095) 0.046 (0.000, 0.096) 0.017
Kumi 0.040 (0.023, 0.057) 0.025 (0.000, 0.051) 0.024
Moroto 0.041 (0.014, 0.069) 0.065 (0.000, 0.132) 0.023
Nakapiripirit 0.049 (0.002, 0.097) 0.038 (0.000, 0.792) 0.018
Napak 0.075 (0.018, 0.132) 0.073 (0.003, 0.143) 0.023
Ngora 0.046 (0.015, 0.078) 0.061 (0.014, 0.108) 0.020
Serere 0.049 (0.029, 0.069) 0.046 (0.014, 0.077) 0.028
Soroti 0.089 (0.060, 0.118) 0.058 (0.019, 0.097) 0.034
South Western
Buhweju 0.035 (0.000, 0.077) 0.022 (0.000, 0.592) 0.025
Bushenyi 0.096 (0.060, 0.132) 0.079 (0.036, 0.123) 0.068
Ibanda 0.065 (0.027, 0.102) 0.053 (0.002, 0.104) 0.059
Isingiro 0.102 (0.061, 0.143) 0.112 (0.064, 0.160) 0.045
Kabale 0.043 (0.024, 0.063) 0.037 (0.010, 0.064) 0.035
Kanungu 0.077 (0.042, 0.112) 0.084 (0.036, 0.131) 0.047
Kiruhura 0.095 (0.046, 0.144) 0.086 (0.025, 0.148) 0.072
Kisoro 0.053 (0.015, 0.091) 0.059 (0.012, 0.105) 0.026
Mbarara 0.101 (0.068, 0.134) 0.124 (0.072, 0.177) 0.059
Mitooma 0.097 (0.042, 0.151) 0.076 (0.012, 0.140) 0.069
Ntungamo 0.063 (0.040, 0.085) 0.062 (0.030, 0.095) 0.050
Rubirizi 0.133 (0.067, 0.199) 0.140 (0.044, 0.236) 0.057
Rukungiri 0.082 (0.053, 0.111) 0.076 (0.038, 0.115) 0.064
Sheema 0.095 (0.056, 0.134) 0.124 (0.063, 0.185) 0.069
West Nile
Adjumani 0.044 (0.020, 0.067) 0.039 (0.012, 0.065) 0.023
Arua 0.043 (0.031, 0.056) 0.049 (0.030, 0.069) 0.035
Koboko 0.048 (0.019, 0.077) 0.063 (0.025, 0.102) 0.025
Maracha 0.029 (0.001, 0.058) 0.007 (0.000, 0.019) 0.014
Moyo 0.033 (0.011, 0.055) 0.037 (0.005, 0.069) 0.019
Nebbi 0.068 (0.045, 0.091) 0.070 (0.042, 0.098) 0.036
Yumbe 0.026 (0.010, 0.042) 0.027 (0.006, 0.048) 0.014
Zombo 0.056 (0.031, 0.082) 0.040 (0.011, 0.069) 0.050
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The mean difference between the HPE and DHIS2 esti-
mates was 0.01 (95% CI: − 0.05,0.06) (Fig. 7a). Average dif-
ference for males was − 0.01 (95% CI: − 0.07, 0.06) while
for females was 0.02 (95% CI: − 0.05, 0.09), (Fig. 7b and c
respectively). The size of the difference increased with in-
crease in the mean of the estimates. This is seen from the
wider variability of the points about the no-difference
(zero) line as the values of the average of the estimates in-
crease (Fig. 7a-c). The average difference was 0.02 and
confidence intervals were wider when comparing HPEs
and survey-based estimates for females (Fig. 7c).
Discussion
In this study, we implement a novel approach, the Hy-
brid Prevalence Estimation methodology to obtain HIV
prevalence estimates for districts in Uganda. We com-
bined DHIS2 HIV testing data with information of non-
facility testers from the 2011 UAIS data to obtain district
level HIV prevalence estimates.
Although national population surveys are the gold
standard for calculating population level health indicators,
district level estimates from these surveys are less accurate
due to the reduced sample sizes at district or lower ad-
ministrative levels. The demand for accurate indicator es-
timates at district or lower administrative levels for
programme monitoring motivates use of innovative ap-
proaches to provide the estimates. We obtained district
level HIV prevalence estimates by combining population
survey information with DHIS2 data using a Hybrid
Prevalence Estimation methodology. Our estimates had
narrower confidence intervals compared to estimates from
the population survey at the district level, consistent with
findings elsewhere [10, 11]. The HPE was calculated from
three parameters; 1) Prevalence in the health facility sam-
ple, 2) prevalence among non-facility testers from the
population survey sample and 3) the propensity to test for
HIV in a health facility from the population survey sam-
ple. We also observed that HIV prevalence estimate
Fig. 2 District Hybrid Prevalence Estimates. Maps created based on study data using Stata Statistical Software: Release 15. User licence was
acquired before using the software
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Fig. 3 District prevalence estimates from combined and population survey data. P_survey- survey based prevalence estimate while P_HPE is HIV
prevalence based on the HPE methodology
Fig. 4 District prevalence estimates from combined and DHIS2 data. P_HIS- Health facility-based prevalence estimate while P_HPE is HIV
prevalence based on the HPE methodology
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obtained using the HPE methodology was similar to the
population survey HIV prevalence estimates for male and
females combined, and for males only while it was lower
for females. Additionally, UAIS based prevalence estimates
were generally higher while DHIS2 prevalence estimates
were lower than the consistent with findings elsewhere
[29].
In the UAIS, the population can be divided into two do-
mains: 1) those that have access to health facilities, get
tested for HIV, and are linked to appropriate care if found
HIV positive, and 2) those that do not access health facil-
ities and may remain unknown in the health care system.
Barriers to health care access for the latter subpopulation
may include factors such as low/no education and not
being in stable sexual relationship that also increase the
risk of HIV transmission [30, 31]. Combining survey with
DHIS2 data therefore generates more precise indicator es-
timates that can be used to improve planning and service
delivery for the general population at district levels where
service delivery decision are implemented.
Facility level data has known limitations including selec-
tion bias, as it is not a random sample from the population
for measuring general population level prevalence [15, 16,
18, 32]. Studies in Uganda [33, 34], Tanzania [35] and
Zambia [36, 37], have also found facility-based antenatal
HIV testing data has biased estimates of HIV prevalence’
and therefore not appropriate for calculating HIV/AIDS in-
dicators including HIV prevalence in the general
Fig. 5 Standard errors of estimates from survey and the HPE
Fig. 6 Difference plot comparing HPE and Direct survey estimates. PREV_HIS- HIV Prevalence based on health facility data, PREV_hp-HIV
prevalence based on the HPE methodology while PREV_dom- HIV prevalence based on survey data only
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population. The HPE methodology requires use of a small
population survey sample [10, 11] to correct for bias in in-
dicator estimates from health facility testing data. We used
Uganda AIDS indicator survey data to correct for the bias
in DHIS2 so as to obtain the HIV prevalence estimates for
districts in Uganda. Other population surveys such as the
demographic and health surveys can be similarly combined
with facility-based data to obtain general population indi-
cator estimates for planning and decision making, espe-
cially in low resourced environments where resource
constraint limits collection of large sample sizes.
We applied a weighting factor, propensity to test in a
health facility, calculated using multilevel logistic regres-
sion to combine the two data sources. Individuals and clus-
ter level predictors of testing for HIV were included in the
model. Predictors of access to testing or health care system
may also impact HIV disease risk as noted elsewhere [10].
Multilevel logistic regression is also appropriate for the
UAIS design and enables inclusion of both individual and
cluster level risk factors in the modelling process. The
model also accounts for clustering [21, 25, 38].
There was no difference in prevalence estimates from
the HPE and Survey based approaches but confidence
intervals of the HPEs were narrower, demonstrating effi-
ciency of the HPE methodology in obtaining population
level estimates as observed elsewhere [11, 18, 39].
Strengths and limitations
We applied multilevel modeling which has multiple advan-
tages over classical models including use of HIV risk factors
at individual and cluster levels. We used data from the
2011 UAIS, a more recent survey, the Population HIV Im-
pact Assessment (PHIA), completed in 2017 was not pub-
licly available at the time of this study. DHS data are prone
to refusal to participate, this may have bias on the results of
this study as those who refuse to participate may have char-
acteristics different from those who participated in the
study. Furthermore, this study was limited to complete case
analysis thus reducing the effective sample size used for the
analysis. DHIS2 data includes individuals who may have
tested multiple times which can lead to the use of wrong or
unrepresentative denominators for individuals tested at
health facilities. Studies elsewhere report repeat testing ran-
ging from 3 to 13% [40, 41]. We further note that some
health facilities, especially privately owned, do not report
their data to the national DHIS2 further lowering the rep-
resentativeness of health facility HIV testing data.
Conclusions
The growing demand for accurate information for
programme management and policy formulation will re-
quire strategies that use all the available information effi-
ciently with little or no additional resource investments.
Countries and development partners continue to build
and strengthen DHIS2 through capacity building and
regular data quality assessments. We applied a simple tool,
HPE methodology, to support efficient use of DHIS data
in combination with small survey samples to obtain more
accurate indicator estimates at district or lower adminis-
trative levels. HPE obtained in this study had reduced
standard errors (by 28.8%) compared to survey-based esti-
mates demonstrating improved accuracy and reliability of
the estimates. We therefore recommend use of the meth-
odology to combine DHIS2 data with population survey
data to obtain population level indicator estimates for
lower administrative levels where the survey samples are
small for accurate indicator estimation.
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